IE32405L - Dehydroepiandrosterone esters - Google Patents
Dehydroepiandrosterone estersInfo
- Publication number
- IE32405L IE32405L IE118468A IE118468A IE32405L IE 32405 L IE32405 L IE 32405L IE 118468 A IE118468 A IE 118468A IE 118468 A IE118468 A IE 118468A IE 32405 L IE32405 L IE 32405L
- Authority
- IE
- Ireland
- Prior art keywords
- oestrogen
- preparations
- esters
- complaints
- preferred
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
1,246,639. Medicines comprising steroids. SCHERING A.G. 30 Sept., 1968 [4 Oct., 1967], No. 46299/68. Heading A5B. [Also in Division C2] Pharmaceutical preparations, suitable for the treatment of climacteric complaints, osteoporosis, deafness due to old age, blood perfusion complaints, heart diseases and depressive states, comprise novel esters of 3 #-hydroxy-#<SP>5</SP>-androsten-17-one with C 7-14 aliphatic carboxylic acids and suitable carriers and/or an oestrogen. Preferred esters are the oenanthate and undecylenate and a preferred oestrogen is oestradiol 17-valerate. Dosage units generally contain 50-500 mg., preferably 100-300 mg., of the ester, and 0.5-10, preferably about 4; mg. of the oestrogen. The preparations are normally in a form suitable for intramuscular infection e.g. oily solutions such as in sesame or castor oil; diluents and/or solubilizing agents e.g. benzyl benzoate, may also be added. Preparations for oral administration are also referred to.
[GB1246639A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESC041382 | 1967-10-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE32405L true IE32405L (en) | 1969-04-04 |
IE32405B1 IE32405B1 (en) | 1973-07-25 |
Family
ID=7436199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE118468A IE32405B1 (en) | 1967-10-04 | 1968-10-03 | Dehydroepiandrosterone esters |
Country Status (12)
Country | Link |
---|---|
AT (1) | AT297946B (en) |
BE (1) | BE721825A (en) |
BR (1) | BR6802861D0 (en) |
CS (1) | CS150596B2 (en) |
DK (1) | DK122125B (en) |
FI (1) | FI45551C (en) |
FR (2) | FR1584879A (en) |
GB (1) | GB1246639A (en) |
IE (1) | IE32405B1 (en) |
NL (1) | NL160835C (en) |
SE (1) | SE352347B (en) |
YU (1) | YU33834B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63267722A (en) * | 1987-04-27 | 1988-11-04 | Daiichi Yakuhin Sangyo Kk | Anti-obesity agent |
US4835147A (en) * | 1987-05-06 | 1989-05-30 | City Of Hope | Dehydroepiandrosterone therapy for ameleoration of prostate hypertrophy and sexual dysfunction |
SK286051B6 (en) * | 1993-01-19 | 2008-02-05 | Endorecherche Inc. | Use of a sex steroid precursor in the preparation of a medicament for preventing or treating reduced or imbalanced concentrations of sex steroids |
US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
US5407927A (en) * | 1993-04-16 | 1995-04-18 | The Regents Of The University Of California | Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone |
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
CN110585124A (en) * | 2019-09-26 | 2019-12-20 | 西安力邦医药科技有限责任公司 | An oily injection containing estriol or its derivatives |
-
1968
- 1968-09-17 DK DK446168A patent/DK122125B/en not_active IP Right Cessation
- 1968-09-19 SE SE1265068A patent/SE352347B/xx unknown
- 1968-09-23 FI FI268068A patent/FI45551C/en active
- 1968-09-25 YU YU224068A patent/YU33834B/en unknown
- 1968-09-27 AT AT09471/68A patent/AT297946B/en not_active IP Right Cessation
- 1968-09-30 GB GB4629968A patent/GB1246639A/en not_active Expired
- 1968-10-01 CS CS681968A patent/CS150596B2/cs unknown
- 1968-10-03 FR FR1584879D patent/FR1584879A/fr not_active Expired
- 1968-10-03 IE IE118468A patent/IE32405B1/en unknown
- 1968-10-03 NL NL6814196A patent/NL160835C/en not_active IP Right Cessation
- 1968-10-04 BE BE721825D patent/BE721825A/xx not_active IP Right Cessation
- 1968-10-04 BR BR20286168A patent/BR6802861D0/en unknown
- 1968-12-27 FR FR181062A patent/FR8191M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI45551C (en) | 1972-07-10 |
YU33834B (en) | 1978-06-30 |
FR1584879A (en) | 1970-01-02 |
BE721825A (en) | 1969-04-04 |
SE352347B (en) | 1972-12-27 |
FR8191M (en) | 1970-09-07 |
NL160835B (en) | 1979-07-16 |
YU224068A (en) | 1977-12-31 |
FI45551B (en) | 1972-04-04 |
GB1246639A (en) | 1971-09-15 |
AT297946B (en) | 1972-03-15 |
BR6802861D0 (en) | 1973-03-15 |
CS150596B2 (en) | 1973-09-04 |
NL6814196A (en) | 1969-04-09 |
NL160835C (en) | 1979-12-17 |
DE1643046B2 (en) | 1975-11-27 |
IE32405B1 (en) | 1973-07-25 |
DE1643046A1 (en) | 1971-06-16 |
DK122125B (en) | 1972-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE32405L (en) | Dehydroepiandrosterone esters | |
Halpern et al. | A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis | |
DE69004532T2 (en) | Medicinal preparations containing topical defibrotide. | |
Menkin | Further Studies on Effect of Adrenal Cortex Extract and of Various Steroids on Capillary Permeability. | |
FI67298B (en) | FRAMEWORK FOR THERAPEUTIC AVERAGE THERAPEUTIC REQUIREMENT FOR STEROID | |
US4181721A (en) | Depot preparations in an oily, unsaturated solution for intramuscular injection | |
Anderson et al. | Comparative pulmonary surfactant-inducing effect of three corticosteroids in the near-term rat | |
FELDMAN et al. | Effect of prolonged use of estrogens on circulating lipids in patients with idiopathic hyperlipemia or idiopathic hypercholesteremia | |
US4076811A (en) | Novel agents and methods for treatment of climacteric disturbances | |
van den Hoogenband et al. | PUVA therapy in the treatment of skin lesions of the hypereosinophilic syndrome | |
Haleblian | Bioassays used in development of topical dosage forms | |
ASADA et al. | Effect of ovariectomy on serum lipid peroxide levels in women | |
Goodman et al. | Hepatocellular carcinoma in association with androgen therapy | |
GB1193464A (en) | Steroidal Esters, Processes for Making them, and Therapeutic Compositions Containing them | |
Opsahl et al. | Chorionic gonadotrophin, ACTH, and the adrenal-hyaluronidase relationship | |
GRAHAM et al. | The influence of adrenal cortical hormones on sensitivity of mice to ionizing radiation | |
GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
Hall | Clinical experiences with the sublingual administration of alpha estradiol | |
FRANK et al. | HYDROCORTISONE (COMPOUND F) FREE ALCOHOL AND HYDROCORTISONE ACETATE FOR TOPICAL USE: A Clinical Evaluation | |
GB1505879A (en) | Acylated orgotein | |
Heimann et al. | EFFECTS OF PLASMOQUIN, ATEBRIN, AND QUININE ON THE ELECTROCARDIOGRAM | |
Crompton et al. | Pulmonary fibrosis, mimicking tuberculosis, presenting before joint symptoms in a female with ankylosing spondylitis | |
Lipschütz et al. | Comparative Conjunctive Tumorigenic Action of Three Different Esters of Estradiol. | |
US3754086A (en) | Stable oily preparations of epithio-steroids | |
Lassus | Local treatment of psoriasis with clobetasol propionate and betamethasone-17, 21 dipropionate: A double-blind comparison |